Wolff-Parkinson-White syndrome, also known as WPW syndrome, is a cardiac disorder characterized by an abnormal electrical pathway in the heart. This condition causes episodes of rapid heart rate or arrhythmia, which can lead to various symptoms and complications.
WPW syndrome is named after the physicians Louis Wolff, John Parkinson, and Paul Dudley White, who first described the condition in the 1930s. It is considered a pre-excitation syndrome as it involves an additional electrical pathway, called an accessory pathway, that bypasses the normal conduction system of the heart.
The presence of this accessory pathway can cause electrical impulses to travel rapidly between the atria and ventricles, resulting in a condition called atrioventricular reentrant tachycardia (AVRT). This leads to episodes of rapid heart rate, palpitations, shortness of breath, dizziness, and even fainting in some cases.
WPW syndrome is often congenital, meaning it is present at birth. However, symptoms may not manifest until later in life. It can occur in individuals with structurally normal hearts or in association with other heart conditions.
Synonyms for Wolff-Parkinson-White syndrome include WPW syndrome, ventricular pre-excitation syndrome, and accessory pathway tachycardia. These terms are used interchangeably to describe the same condition.
Diagnosis of WPW syndrome involves various tests, including electrocardiogram (ECG), echocardiogram, and electrophysiological studies. Treatment options depend on the severity of symptoms and may include medications, catheter ablation, or in rare cases, surgery.
It is important for individuals with WPW syndrome to receive proper medical evaluation and management to prevent complications such as rapid heart rate, atrial fibrillation, or even sudden cardiac arrest. Regular follow-up with a cardiologist is recommended to monitor the condition and adjust treatment as necessary.